𝗔𝗽𝗽𝗹𝗶𝗰𝗮𝘁𝗶𝗼𝗻𝘀 𝗮𝗿𝗲 𝗰𝘂𝗿𝗿𝗲𝗻𝘁𝗹𝘆 𝗯𝗲𝗶𝗻𝗴 𝗮𝗰𝗰𝗲𝗽𝘁𝗲𝗱 𝗳𝗼𝗿 𝘁𝘄𝗼 𝘁𝗿𝗮𝗰𝗸𝘀:
🔬 Life Sciences applications close November 2, 2026.
🖥️ Digital Health applications close November 30, 2026.

Learn more about the BEE program and apply today: app.scalehealth.com/sites/bright...

Are you a cancer researcher working to bring your newest breakthrough out of the lab and into the clinic?

Consider applying for the 𝗔𝗖𝗦 𝗕𝗿𝗶𝗴𝗵𝘁𝗘𝗱𝗴𝗲 𝗘𝗻𝘁𝗿𝗲𝗽𝗿𝗲𝗻𝗲𝘂𝗿𝘀 𝗣𝗿𝗼𝗴𝗿𝗮𝗺!

app.scalehealth.com/sites/bright...

5. A new @jamanetworkopen.com study from ACS Research Scholar grantee and visiting scientist Dr. Xin (Cynthia) Hu and our intramural cancer surveillance team comparing palliative care usage among Medicare Advantage and traditional Medicare beneficiaries with advanced cancer.

doi.org/10.1001/jama...

4. A new @narjournal.bsky.social paper from senior author @danyarango.bsky.social that revealed a transcript- and site-specific inhibitory role for 2'-O-methylation in translation initiation.

ACS supported this work through co-author Dr. Yang Yi's Research Scholar Grant.

doi.org/10.1093/nar/...

3. A new publication in 𝘊𝘢𝘯𝘤𝘦𝘳 𝘙𝘦𝘴𝘦𝘢𝘳𝘤𝘩 from senior author Dr. Thomas McFall investigating how different KRAS alleles influence resistance mechanisms to the RAS inhibitor daraxonrasib in pancreatic cancer.

Dr. McFall is one of four ACS IRG subawardees on the paper.

doi.org/10.1158/0008...

2. A new @science.org study that demonstrated senescence-modulating nanoparticles targeting P-selectin on senescent-like cells can reduce fibrosis and enhance immune response in cancer.

ACS supported this work through @danielheller.bsky.social's Research Scholar Grant.

doi.org/10.1126/scie...

1. New research published in 𝘚𝘤𝘪𝘦𝘯𝘤𝘦 𝘈𝘥𝘷𝘢𝘯𝘤𝘦𝘴 by senior author Dr. David Bilder demonstrating a mechanism that can be exploited by tumors to reduce immune responses in Drosophila, promoting tumor progression and host mortality.

Dr. Bilder is a Discovery Boost grantee.

doi.org/10.1126/scia...

It's time for this week's #ACSFriday5... on a Saturday!

Because even a day late, these great new papers from our ACS researchers deserve their moment in the spotlight:

#CanSky #OncoSky 🧪

𝗣𝗹𝗲𝗮𝘀𝗲 𝘀𝘂𝗯𝗺𝗶𝘁 𝘆𝗼𝘂𝗿 𝗻𝗼𝗺𝗶𝗻𝗮𝘁𝗶𝗼𝗻 𝗼𝗻 𝗼𝗿 𝗯𝘆 𝟱:𝟬𝟬𝗽𝗺 𝗘𝗧, 𝗢𝗰𝘁𝗼𝗯𝗲𝗿 𝟯𝟭, 𝟮𝟬𝟮𝟲 𝗯𝘆 𝗰𝗼𝗺𝗽𝗹𝗲𝘁𝗶𝗻𝗴 𝘁𝗵𝗲 𝗠𝗲𝗱𝗮𝗹 𝗼𝗳 𝗛𝗼𝗻𝗼𝗿 𝗡𝗼𝗺𝗶𝗻𝗮𝘁𝗶𝗼𝗻 𝗙𝗼𝗿𝗺 𝗮𝘁 amercancer.co/MOH2027_Nomi....

If you have any questions, please email [email protected].

🏅 𝗖𝗮𝗹𝗹 𝗳𝗼𝗿 𝗠𝗲𝗱𝗮𝗹 𝗼𝗳 𝗛𝗼𝗻𝗼𝗿 𝗡𝗼𝗺𝗶𝗻𝗮𝘁𝗶𝗼𝗻𝘀! 🏅

The Medal of Honor is the highest award given by ACS to recognize an individual whose work has led to a significant scientific or clinical advancement.

𝗣𝗹𝗲𝗮𝘀𝗲 𝘀𝘂𝗯𝗺𝗶𝘁 𝘆𝗼𝘂𝗿 𝗻𝗼𝗺𝗶𝗻𝗮𝘁𝗶𝗼𝗻 𝗯𝗲𝗳𝗼𝗿𝗲 𝟱:𝟬𝟬𝗽𝗺 𝗘𝗧, 𝗢𝗰𝘁𝗼𝗯𝗲𝗿 𝟯𝟭, 𝟮𝟬𝟮𝟲 𝗮𝘁 amercancer.co/MOH2027_Nomi...

𝗢𝘁𝗵𝗲𝗿 𝗸𝗲𝘆 𝗳𝗶𝗻𝗱𝗶𝗻𝗴𝘀:

- An est'd 229,900 Hispanic people will be diagnosed with cancer this year, & 54,200 will die from the disease.

- 36% higher rates of cervical cancer in Hispanic vs White women & double the rates of liver and stomach cancers.

🔗 Read the full report: doi.org/10.3322/caac...

🚨 𝗡𝗲𝘄 𝗖𝗮𝗻𝗰𝗲𝗿 𝗦𝘁𝗮𝘁𝗶𝘀𝘁𝗶𝗰𝘀 𝗢𝘂𝘁 𝗧𝗼𝗱𝗮𝘆! 🚨

Published today in 𝘊𝘈: 𝘈 𝘊𝘢𝘯𝘤𝘦𝘳 𝘑𝘰𝘶𝘳𝘯𝘢𝘭 𝘧𝘰𝘳 𝘊𝘭𝘪𝘯𝘪𝘤𝘪𝘢𝘯𝘴, this new report from our Cancer Surveillance team reveals 𝗰𝗮𝗻𝗰𝗲𝗿 𝗶𝘀 𝘁𝗵𝗲 𝗹𝗲𝗮𝗱𝗶𝗻𝗴 𝗰𝗮𝘂𝘀𝗲 𝗼𝗳 𝗱𝗲𝗮𝘁𝗵 𝗶𝗻 𝘁𝗵𝗲 𝗛𝗶𝘀𝗽𝗮𝗻𝗶𝗰 𝗮𝗻𝗱 𝗟𝗮𝘁𝗶𝗻𝗼 𝗰𝗼𝗺𝗺𝘂𝗻𝗶𝘁𝘆 𝗶𝗻 𝘁𝗵𝗲 𝗨𝗻𝗶𝘁𝗲𝗱 𝗦𝘁𝗮𝘁𝗲𝘀.

#CanSky #OncoSky #OncoAlert

Dr. Patel shared findings from a recent survey of 33,000 participants enrolled in our Cancer Prevention Study-3, which uncovered significant gaps between what women know about cancer risk and the healthy behaviors that can help reduce it.

Read the full survey report at amercancer.co/CPS3BCAMSurvey

𝗔𝗖𝗦 𝗥𝗲𝘀𝗲𝗮𝗿𝗰𝗵 𝗶𝗻 𝘁𝗵𝗲 𝗻𝗲𝘄𝘀!

Earlier today, Dr. Alpa Patel, Senior Vice President for Population Science, made an appearance on 𝘎𝘰𝘰𝘥 𝘔𝘰𝘳𝘯𝘪𝘯𝘨 𝘈𝘮𝘦𝘳𝘪𝘤𝘢 to kick off #BreastCancerAwarenessMonth.

abcnews.com/video/136915...

#BCAM #CancerRisk #CanSky #OncoSky

🚨𝗪𝗲𝗯𝗶𝗻𝗮𝗿 𝗥𝗲𝗺𝗶𝗻𝗱𝗲𝗿 - 𝗧𝗢𝗗𝗔𝗬! 🚨

This afternoon, we will host our final Grant Opportunities Webinar for our current grant application cycle. Please join us from 4-5pm ET today to learn about our current grant funding opportunities!

🔗 Register in advance here: amercancer.co/Fall2026ACSG...

5. A new review in 𝘙𝘢𝘥𝘪𝘰𝘭𝘰𝘨𝘺 from lead author Dr. Rony Avritscher discussing the integration of yttrium 90 (90Y) radioembolization with immunotherapy for advanced-stage hepatocellular carcinoma (HCC).

Dr. Avritscher is an ACS Research Scholar grantee.

doi.org/10.1148/radi...

4. A new @moltherapy.bsky.social paper from senior author Dr. Ji Young Yoo and their team describing their work on therapy-induced IGF1R signaling as an actionable vulnerability in oncolytic virotherapy.

ACS supported this work through Dr. Yoo's Research Scholar Grant.

doi.org/10.1016/j.ym...